Literature DB >> 16950997

Electrocardiography in the diagnosis of right ventricular hypertrophy in children.

Michael D Puchalski1, John S Lozier, David J Bradley, L LuAnn Minich, Lloyd Y Tani.   

Abstract

OBJECTIVE: Although the electrocardiogram is commonly obtained in the evaluation of patients with pulmonary hypertension, its value as a screening test for right ventricular hypertrophy or pulmonary hypertension is unclear. Therefore, we sought to determine the value of an electrocardiogram in the diagnosis of right ventricular hypertrophy using echocardiography as the gold standard.
METHODS: We identified children without congenital heart disease who underwent evaluation for suspected pulmonary hypertension that included both an electrocardiogram and echocardiography within a specified time frame.
RESULTS: A total of 76 echocardiography-electrocardiogram pairs for pulmonary hypertension were identified. Although there was a significant relationship between electrocardiogram and echocardiography evidence of right ventricular hypertrophy, the sensitivity of an electrocardiogram in diagnosing echocardiography-documented right ventricular hypertrophy was only 69%, and the positive predictive value was 67%. There was no relationship between electrocardiogram changes and Doppler tricuspid regurgitation gradient.
CONCLUSION: Despite a statistically significant relationship between an electrocardiogram and echocardiography in the diagnosis of right ventricular hypertrophy, an electrocardiogram has limited value as a screening tool for right ventricular hypertrophy because of its relatively low sensitivity and positive predictive value.

Entities:  

Mesh:

Year:  2006        PMID: 16950997     DOI: 10.1542/peds.2005-2985

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.

Authors:  Hui-Hsuan Chung; Zen-Kong Dai; Bin-Nan Wu; Jwu-Lai Yeh; Chee-Yin Chai; Koung-Shing Chu; Chung-Pin Liu; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

3.  A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.

Authors:  Dunbar Ivy; Ben T Saji
Journal:  Nihon Shoni Junkanki Gakkai Zasshi       Date:  2010-06-04

4.  Pulmonary hypertension in infants with bronchopulmonary dysplasia.

Authors:  Gi Beom Kim
Journal:  Korean J Pediatr       Date:  2010-06-23

5.  Pulmonary arterial hypertension: advances in pathophysiology and management.

Authors:  Sandeep Chopra; Dinesh K Badyal; P Chris Baby; Davis Cherian
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

6.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.